Radiological features of Paget disease of bone associated with VCP myopathy

Skeletal Radiology

Volumn 41, Issue 3, 2012, Pages 329-337

  Farpour, Farzin ^a,f   Tehranzadeh, Jamshid ^a   Donkervoort, Sandra ^b   Smith, Charles ^c   Martin, Barbara ^d   Vanjara, Pari ^b   Osann, Kathryn ^b   Kimonis, Virginia E ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f QUEENS HOSPITAL CENTER   (United States)

Author keywords

Alkaline phosphatase; Frontotemporal dementia; IBMPFD; Inclusion body myopathy; Paget's disease of bone; Presymptomatic; Valosin containing protein

Indexed keywords

ALKALINE PHOSPHATASE; VALOSIN CONTAINING PROTEIN; ADENOSINE TRIPHOSPHATASE; CDC48 PROTEIN; CELL CYCLE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE RADIOGRAPHY; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE MARKER; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; INCLUSION BODY MYOSITIS; LABORATORY TEST; MALE; MUSCLE DISEASE; MYOPATHY; ONSET AGE; PAGET BONE DISEASE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; TREATMENT RESPONSE; VCP GENE; GENETICS; RADIOGRAPHY;

ADENOSINE TRIPHOSPHATASES; ADULT; AGED; CELL CYCLE PROTEINS; FEMALE; HUMANS; MALE; MYOSITIS, INCLUSION BODY; OSTEITIS DEFORMANS;

EID: 84861523046     PISSN: 03642348     EISSN: 14322161     Source Type: Journal    
DOI: 10.1007/s00256-011-1193-4     Document Type: Article

References (21)

1. Colina M et al. Paget's disease of bone: a review. Rheumatol Int. 2008;28(11):1069-75.
2. Lucas GJ et al. Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Bone. 2006;38(2):280-5. (Pubitemid 43165794)
3. Kimonis VE et al. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet Med. 2000;2(4):232-41. (Pubitemid 32010830)
4. Kovach MJ et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab. 2001;74 (4):458-75. (Pubitemid 34084655)
5. Watts GD et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36(4):377-81. (Pubitemid 38437260)
6. Vesa J et al. Valosin-containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul Disord. 2009;19(11):766-72.
7. Kimonis VE et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A. 2008;146(6):745-57. (Pubitemid 351354150)
8. Mirra JM, Brien EW, Tehranzadeh J. Paget's disease of bone: review with emphasis on radiologic features, Part II. Skeletal Radiol. 1995;24(3):173-84.
9. Noor M, Shoback D. Paget's disease of bone: diagnosis and treatment update. Curr Rheumatol Rep. 2000;2(1):67-73.
10. Watts GD et al. Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes. Neuromuscul Disord. 2003;13(7-8):559-67. (Pubitemid 36961345)
11. Kimonis VE, et al. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta, 2008.
12. Kimonis V, Watts G. Inclusion Body Myopathy Associated with Paget Disease of Bone and/or Frontotemporal Dementia Gene. Seattle: GeneTests (www.genetests.org) and University of Washington; 2007.
13. Kimonis VE, Watts GD. Autosomal dominant inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Alzheimer Dis Assoc Disord. 2005;19 Suppl 1:S44-7. (Pubitemid 44378507)
14. Dahlin DC, Cupps RE, Johnson Jr EW. Giant-cell tumor: a study of 195 cases. Cancer. 1970;25(5):1061-70.
15. Kimonis VE et al. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta. 2008;1782(12):744-8.
16. Whyte MP. Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. Ann NY Acad Sci. 2006;1068:143-64. (Pubitemid 43824145)
17. Siris ES et al. Familial aggregation of Paget's disease of bone. 1991. J Bone Miner Res. 2005;20(3):542-7.
18. Eekhoff ME et al. Paget's disease of bone in The Netherlands: a population-based radiological and biochemical survey-the Rotterdam Study. J Bone Miner Res. 2004;19(4):566-70. (Pubitemid 41071216)
19. Kimonis, V and Watts, G. Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia. Seattle: GeneT-ests (www.genetests.org) and University of Washington; 2007.
20. Singer FR et al. Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease. J Clin Endo-crinol Metab. 1998;83(6):1906-10. (Pubitemid 28496314)
21. Visconti MR et al. Mutations of SQSTM1 are associated with severity and clinical outcome in Paget disease of bone. J Bone Miner Res. 2010;25(11):2368-73.